• Users Online: 3005
  • Print this page
  • Email this page
This article has been cited by
1Perioperative adverse events attributed to a2-adrenoceptor agonists in patients not at risk of cardiovascular events: systematic review and meta-analysis
Migena Demiri,Tiago Antunes,Dominique Fletcher,Valeria Martinez
British Journal of Anaesthesia.2019;123(6)795
[DOI]
2Effects of serum from breast cancer surgery patients receiving perioperative dexmedetomidine on breast cancer cell malignancy: A prospective randomized controlled trial
Yan Liu,Jiaxin Sun,Tong Wu,Xiaoying Lu,Yueyao Du,Hongwei Duan,Weifeng Yu,Diansan Su,Jinsong Lu,Jie Tian
Cancer Medicine.2019;8(18)7603
[DOI]
3Safety and Efficacy of Dexmedetomidine in Breast Surgeries: A Systematic Review and Meta-Analysis
Ehsan Motaghi,Masumeh Ghasemi Pirbalooti,Hooman Bozorgi,Majid Eslami,Mohsen Rashidi
Journal of PeriAnesthesia Nursing.2020;8(18)7603
[DOI]
4Dexmedetomidine as an adjuvant for patients undergoing breast cancer surgery
Changjun Liu,Wei Wang,Zhengkun Shan,Huapeng Zhang,Qiang Yan
Medicine.2020;99(50)e23667
[DOI]